LightPath Technologies Reports Third Quarter Fiscal 2025 Financial Results
Prnewswire· 2025-05-15 20:05
ORLANDO, Fla., May 15, 2025 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced financial results for its fiscal third quarter ended March 31, 2025.Financial Summary: Three Months Ended March 31, $ in millions 2025 2024 % Change Revenue $9.2 $7.7 19.1 % Gross Profit $2.7 $1.6 65.9 % Operating Expenses $ ...
Quantum Computing Inc. Reports First Quarter 2025 Financial Results
Prnewswire· 2025-05-15 20:05
HOBOKEN, N.J., May 15, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), an innovative, integrated photonics and quantum optics technology company, today released financial results for the three-month period ended March 31, 2025.Dr. Yuping Huang, Interim Chief Executive Officer of QCi, commented, "QCi delivered solid operational and financial progress in the first quarter, strengthening our balance sheet and advancing key strategic initiatives. We completed construction du ...
Neurocrine Biosciences Presents Data on Improvements in Physiologic Glucocorticoid Dosing and Select Reproductive Hormones in Patients with Classic Congenital Adrenal Hyperplasia Taking CRENESSITY™ (crinecerfont)
Prnewswire· 2025-05-15 20:05
90% of Pediatric Participants on CRENESSITY versus 21% on Placebo Achieved ≥1 Threshold for Androstenedione Reduction or Glucocorticoid Reduction Observed Rates of Select Reproductive Hormone Normalization in Adult Males Taking CRENESSITY with Substantial Glucocorticoid Dose Reductions Findings Presented at the 2025 American Association of Clinical Endocrinology Annual MeetingSAN DIEGO, May 15, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new data from the Phase 3 CAHtal ...
BioHarvest Sciences Reports First Quarter 2025 Financial Results
Newsfile· 2025-05-15 20:05
BioHarvest Sciences Reports First Quarter 2025 Financial ResultsFirst Quarter Revenues Grew 47% to $7.9 Million, Exceeding Management GuidanceMay 15, 2025 4:05 PM EDT | Source: BioHarvest Sciences Inc.Rehovot, Israel--(Newsfile Corp. - May 15, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the first quarter ended March ...
Petco Health and Wellness Company, Inc. to Host First Quarter 2025 Earnings Conference Call on June 5, 2025
Prnewswire· 2025-05-15 20:05
SAN DIEGO, May 15, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), today announced that its financial results for the first quarter fiscal 2025 will be released after market close on Thursday, June 5, 2025. The company will host a conference call at 4:30 p.m. Eastern time to discuss the results.A live webcast of the conference call will be available on the company's Investor Relations page at https://ir.petco.com/news-and-events/events-and-presentations. A replay of the webcast ...
Docusign Announces Timing of First Quarter Fiscal 2026 Earnings Conference Call
Prnewswire· 2025-05-15 20:05
SAN FRANCISCO, May 15, 2025 /PRNewswire/ -- Docusign (Nasdaq: DOCU) today announced that its first quarter fiscal 2026 results will be released on Thursday, June 5, 2025, after the close of the market. The company will host a conference call at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time) to discuss its financial results. A live webcast of the event will be available on the Docusign Investor Relations website at investor.docusign.com. A live dial-in will be available domestically at 877 ...
BrainStorm Cell Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update
Prnewswire· 2025-05-15 20:05
Conference call and webcast rescheduled for 8:30 a.m. Eastern Time on Monday, May 19NEW YORK, May 15, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the first quarter ended March 31, 2025, and provided a corporate update."BrainStorm continues to make meaningful progress in advancing our NurOwn® development program. Our priority continues to be initiation of a Phas ...
Hormel Foods Announces Retirement of Scott Aakre, Group Vice President and Chief Marketing Officer for Retail, Following a Distinguished 35-year career
Prnewswire· 2025-05-15 20:05
Aakre extends his service to the company by joining Hormel Foods board of directorsAUSTIN, Minn., May 15, 2025 /PRNewswire/ -- Hormel Foods Corporation (NYSE: HRL), a Fortune 500 global branded food company, announced that Scott Aakre, group vice president and chief marketing officer for Retail, will retire at the end of the company's fiscal 2025 after 35 years of distinguished service. His responsibilities will be transitioned internally. The company also announced that Aakre, who serves on The Hormel Foun ...
Nutrien Ltd. (NTR) BMO 2025 Farm to Market Conference (Transcript)
Seeking Alpha· 2025-05-15 20:04
Nutrien Ltd. (NYSE:NTR) BMO 2025 Farm to Market Conference May 15, 2025 11:00 AM ET Company Participants Mark Thompson - EVP, Chief Commercial Officer & CFO Conference Call Participants Joel Jackson - BMO Capital Markets Joel Jackson All right. Let's continue on here with our next fireside chat. It's going to be from Nutrien, world's largest fertilizer producer, owns a large farm center business, very influential in potash and nitrogen. So, we're happy to welcome the CFO of the company, Mark Thompson. Mark, ...
Onity Group: Fundamentals Got Stronger As The Book Value Discount Narrows (Upgrade)
Seeking Alpha· 2025-05-15 20:04
I covered Onity Group (NYSE: ONIT ) on the 9th of April, last month. The stock was trading at $29.48, and now it's trading at $39 per share, a more than 30% increase in one month. My original thesis was that ONITI'm a self taught equity analyst, I run a consultation firm in South Africa where we help clients with estimating the value of construction projects, over the past 5 years I've been retail investing and learning more about how the stock market works, following the work of Ben Graham and Joel Greenbl ...